Why Cryopreservation is No Longer Science Fiction with Until Co-founder and CEO Laura Deming

Laura Deming, co-founder and CEO of Until, discusses the frontier of reversible cryopreservation, from human organs to whole bodies, and its potential implications. The conversation centers on using cryopreservation as a form of critical care, particularly for patients awaiting medical breakthroughs. Deming highlights the challenge of ice formation during the freezing process and the surprising fact that reversible cryopreservation is already successfully performed on human embryos. She emphasizes the trade-off between engineering and biology in cryopreservation, noting that improved engineering can reduce the biological challenges. Deming envisions a future where organ transplantation is transformed by making time not a variable, improving the experience for both patients and surgeons.